Scar Classification · Recurrence Risk · CityLink Mall

Keloids and Hypertrophic Scars Singapore —
Where The Scar Stops

A hypertrophic scar stays within the boundary of the original wound. A keloid does not — it grows outward into skin that was never injured — and that single difference changes the recurrence risk, the treatment sequence, and whether cutting it out is a reasonable idea at all.

The Mechanism

A Repair That Never Stops

Book a Consultation

Ordinary wound healing has an ending. Inflammation gives way to proliferation, fibroblasts lay down collagen to bridge the defect, and then remodelling begins — the disorganised type III collagen of early repair is gradually replaced by aligned type I collagen, the excess is broken down by matrix metalloproteinases, and the scar flattens and pales over roughly a year. Raised scars are what happens when the third phase never properly arrives.

In both keloids and hypertrophic scars, fibroblasts in the wound bed stay activated long past the point where they should have quietened. They continue producing collagen, and the enzymes that would normally degrade the surplus are outpaced or suppressed. The result is a scar with far more collagen than the defect required, bulging above the surface of the surrounding skin. Sustained inflammation keeps that loop running, which is why wounds under tension, wounds that became infected, and wounds that healed slowly are the ones that most often end up raised.

The two conditions diverge in how far that activity spreads. Hypertrophic scarring is contained — the overactive tissue respects the edge of the original injury and the scar, however thick, sits within the footprint of the wound that caused it. In a keloid the fibroproliferative process behaves invasively, recruiting fibroblasts in the surrounding dermis and extending claw-like into skin that was never cut. That is not a cosmetic distinction. It is the reason a keloid will not settle on its own and the reason a wider excision simply produces a wider keloid.

Genetics govern susceptibility more than anything a patient did or did not do. Keloids are substantially more common in darker Fitzpatrick skin types, frequently run in families, and cluster at sites with high skin tension and thick dermis — the sternum, the deltoid and shoulder, the upper back, the jawline and the earlobe after piercing. Someone who has formed one keloid should assume they will form another from the next comparable injury, and plan accordingly.

Driver One
Persistent Fibroblast Activity
The cells that lay down repair collagen fail to receive or obey the signal to stop. Collagen synthesis continues well beyond what the wound needed, and the surplus accumulates rather than being remodelled away.
Driver Two
Prolonged Inflammation
Infection, foreign material, repeated trauma and slow healing all keep inflammatory signalling switched on. A wound that took a long time to close is far more likely to end up raised than one that healed cleanly.
Driver Three
Mechanical Tension
Skin under constant stretch transmits force to the healing wound, and fibroblasts respond to mechanical load by producing more collagen. This is why the chest, shoulders and upper back are the classic keloid sites.
Driver Four
Individual Susceptibility
Keloid tendency is strongly heritable and markedly more common in Fitzpatrick IV to VI skin. It is a property of the person, not a failure of wound care, and it does not disappear with age.

Classification

Two Scars, One Appearance

Patients describe both as a lump, and photographs alone rarely settle it. The question that decides the diagnosis is geometric: does the raised tissue stay inside the line of the original injury, or has it crossed it. The answer determines how the scar will behave over the next five years and how aggressively it needs to be managed.

Cutting out a keloid and doing nothing else is how a small keloid becomes a large one.

Dr. Sin Yong · Medical Director, Atelier Aesthetics

Specifications

Region
Chest, shoulder, upper back, earlobe, jawline — high-tension and thick-dermis sites
Assessment
Boundary relative to the original wound, duration, symptoms, prior recurrence, family history, Fitzpatrick type
Classification
Hypertrophic — confined to the wound. Keloid — extending beyond it.
Review
Response assessed over months, not weeks; recurrence watched for well beyond the first year
Type I
Hypertrophic Scar
Raised, often red and firm, sometimes itchy, but entirely contained within the boundary of the original wound. It typically appears within the first two months, may worsen for six, then slowly softens and flattens over one to two years. It responds well to treatment and recurs far less readily once settled.
Type II
Keloid
Extends beyond the original injury into normal skin, often with irregular projections. Onset may be delayed by months and it does not regress spontaneously. It is frequently itchy or tender, continues to enlarge, and recurs after excision alone at high rates. Management assumes recurrence and plans against it.
Type III
Contracture and Atrophic Scars
Scars that tighten across a joint and restrict movement belong to a plastic surgeon, not an aesthetic clinic. Depressed scars — the opposite problem, too little collagen — are a different condition entirely and are addressed through scar reconstruction rather than flattening.

Management

Why Excision Alone Fails

A keloid removed surgically and closed without any adjunct treatment recurs in the great majority of cases, and the recurrence is often larger than the original — because the excision is itself a fresh injury in skin that has already demonstrated exactly how it responds to injury. This is the single most important thing to understand before agreeing to have one cut out. Surgery has a place in keloid management, but only inside a planned regimen that suppresses the fibroproliferative response afterwards, and only when the patient understands they are committing to months of follow-up rather than a single appointment.

The approaches that genuinely change raised scar tissue work by interrupting the mechanism rather than removing the bulk. Intralesional corticosteroid suppresses fibroblast activity and inflammation and softens the scar from within. Silicone, occlusion and pressure act on hydration and mechanical load. Vascular and fractional laser work reduces the vessel-rich redness and remodels collagen architecture in a controlled way. In practice these are combined and sequenced, not chosen between — and keloid treatment is measured in review appointments over a year rather than a course of three.

Timing also matters at the other end. If you are keloid-prone and are contemplating any elective procedure that breaks the skin — a piercing, a mole excision, a cosmetic incision — that susceptibility belongs in the conversation beforehand. It is far easier to manage a wound prophylactically from the day it closes than to treat an established keloid two years later. Atelier Aesthetics will say plainly where a scar is beyond what a non-surgical approach can achieve, or where the right next step is a plastic surgical referral.

How keloids are treated

FAQ

Keloids and Hypertrophic Scars — Common Questions

Ask a Question
Look at the edge. If the raised tissue stops exactly where the original cut, burn or spot was, it is hypertrophic. If it has spread sideways into skin that was never injured — often with irregular lobes or projections — it is a keloid. Timing helps too: hypertrophic scars usually appear within weeks and slowly improve after the first six months, while keloids may start months later and keep growing. The distinction is made clinically, from the history and the boundary, rather than from a scan.
No. Hypertrophic scars frequently flatten and pale substantially over one to two years without intervention, which is why patience is a legitimate option for some of them. Keloids do not regress spontaneously. Left alone they remain, and many continue to enlarge slowly for years. Waiting is not a strategy for a keloid — it simply means treating a larger lesion later.
Susceptibility is genetic and is strongly associated with Fitzpatrick IV to VI skin types, which in Singapore means a considerable proportion of the population is at elevated risk. The precise reason is not fully settled, but it involves inherited differences in fibroblast behaviour and inflammatory signalling rather than anything to do with skin care. It is a tendency to be planned around, and it also means device settings and treatment choices have to account for a higher post-inflammatory pigmentation risk alongside the scarring risk.
It can, but excision on its own has a high recurrence rate and frequently produces a larger keloid than the one removed, because the operation is a new wound in skin that scars badly. Surgery is defensible only as part of a combined plan with post-operative suppression of the fibroproliferative response and structured follow-up. Anyone offering removal as a one-appointment solution is not describing how this tissue behaves.
They are somewhat more favourable than chest or shoulder keloids, largely because the earlobe carries little skin tension and the lesion is usually pedunculated rather than broadly based. They still recur, and they still require an adjunct plan rather than excision alone, but combined management on the earlobe tends to give better and more durable results than at high-tension sites. They are also the site where a repeat piercing through treated tissue reliably restarts the process.
Not necessarily, but the plan changes. Procedures that create open wounds or deep controlled injury warrant a more cautious approach, test areas, and a prophylactic regimen from the day of treatment. Non-wounding modalities are often preferable. The important step is disclosing the tendency at consultation rather than afterwards, so that treatment choice, energy settings and aftercare are designed around it. Tell the doctor before, not after.

Continue

Related at Atelier

More on this topic

Atelier Aesthetics · Owned by AYA

Classified first —
then managed.

1 Raffles Link, #B1-28, CityLink Mall, Singapore 039393 · +65 8023 7170

Book a Consultation